title: Assessment of activated partial thromboplastin time and factor IX in subjects attending an anticoagulation clinic.
abstract: Very low factor IX (FIX) levels in patients during oral anticoagulant (OA) treatment, due to mutations in the FIX gene, with prolonged activated partial thromboplastin time (aPTT) and associated with bleeding complications have recently been described. We measured aPTT in 595 OA patients while being within therapeutic ranges. Patients were divided into increasing international normalized ratio (INR) classes, and FIX determined in those belonging to the first and fifth quintiles of the aPTT distribution in each INR class. Results obtained in patients of all the first aPTT quintiles were compared with those of all the fifth quintiles. While INR was not different (2.79 versus 2.77 INR), aPTT was longer (1.65 versus 1.21 ratio; P < 0.0001) and FIX lower (0.29 versus 0.44 IU/ml; P < 0.0001) in patients of the fifth quintiles. Only one patient had a markedly reduced FIX (0.03 IU/ml). Bleeding rate was 4.8 and 6.2% patient-years (not significant) in patients of the first and fifth quintiles, respectively. We therefore found that FIX levels vary greatly in spite of similar achieved anticoagulation intensity; very low FIX is, however, a rare condition. In conclusion, screening for the recently identified mutations in FIX gene does not seem justified, and identifying patients with disproportionately prolonged aPTT, to detect those with particularly low FIX levels, is difficult because of the effect of the achieved anticoagulation intensity. Therefore, aPTT measurement is indicated only in patients with increased bleeding during OA.
authors.affiliation: Department of Angiology and Blood Coagulation, University Hospital S. Orsola, Bologna, Italy. legnanic@tin.it
authors.forename: C
authors.initials: C
authors.lastname: Legnani
authors.forename: M
authors.initials: M
authors.lastname: Promenzio
authors.forename: G
authors.initials: G
authors.lastname: Guazzaloca
authors.forename: S
authors.initials: S
authors.lastname: Coccheri
authors.forename: G
authors.initials: G
authors.lastname: Palareti
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage; D000075202:Contraindications; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D005164:Factor IX / Q000378:metabolism*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D012044:Regression Analysis; D012189:Retrospective Studies
chemical_list: D000925:Anticoagulants; D005164:Factor IX